IFM | Evaluating Changes to Meningococcal Vaccination Schedules

In this special edition of 'Inside Family Medicine', sponsored by Sanofi, Dr. Jana Shaw and Dr. Peter Ziemkowski discuss potential changes to the meningococcal vaccination schedule. Key topics include the current two-dose vaccination schedule, proposed alternative schedules, recent research findings, and the potential implications of schedule changes on public health, health equity, and disease prevention. The episode emphasizes the importance of maintaining the current vaccination schedule for effective disease prevention and highlights the significance of timely vaccinations in protecting adolescents and young adults. This episode was sponsored by Sanofi. The research discussed was developed through Sanofi funding. Topics by Timestamp 00:00 Introduction to Inside Family Medicine 00:46 Meet the Experts: Dr. Jana Shaw and Dr. Peter Ziemkowski 02:13 Current Meningococcal Vaccination Schedule 04:23 Proposed Changes to the Vaccination Schedule 05:59 Research Findings on Vaccination Schedule Changes 09:19 Impact on Health Equity and Access 12:40 Advice for Family Physicians and Policymakers 16:24 Conclusion and Additional Resources Additional Resources Research studies and related articles Assessing the Impact of Revising MenACWY Vaccination Schedule for Adolescents in the United States: A Modelling Study by Affan Shoukat, Chad Wells, Thomas Shin, Lilia Potter-Schwartz, Alison P. Galvani, Seyed M. Moghadas :: SSRN Quadrivalent Conjugate Vaccine and Invasive Meningococcal Disease in US Adolescents and Young Adults | Public Health | JAMA Network Open | JAMA Network Article by podcast guest Dr Jana Shaw - Risks of removing the age 11–12-year meningococcal vaccine dose from the US immunization schedule - ScienceDirect Clinician Resources: Meningitis information on aafp.org Patient Resources: https://familydoctor.org/condition/meningitis/ Related Activities: Leading Edge LinkedIn Live, October 5, 2025 This episode was sponsored by Sanofi. The research discussed was developed through Sanofi funding. Disclaimer: Copyright 2025. AAFP. The views presented in this broadcast are the speaker's own and do not represent those of AAFP.  The information presented is for general, educational, or entertainment purposes and should not be considered legal, health, financial, or other advice.  AAFP makes no representation as to the accuracy or completeness of the information and is not responsible for results that may arise from its use.  Consult an appropriate professional concerning your specific situation and respective governing bodies for applicable laws. Reference to any specific product or entity does not constitute an endorsement or recommendation by AAFP unless specifically stated otherwise.  AAFP and the AAFP logo are registered trademarks of American Academy of Family Physicians.